M. M. Haley et al.
7.73–7.69 (m, 2H), 7.55–7.51 (m, 1H), 7.42–7.39 (m, 1H), 3.9–3.8 (m,
4H), 1.36 (t, J=7.2 Hz, 6H), 0.33 ppm (s, 9H); 13C NMR (CDCl3): d=
151.4, 134.4, 131.2, 129.1, 127.9, 126.8, 126.1, 125.0, 116.5, 113.5, 104.0,
101,2, 49.2, 42.0, 14.5, 11.0 ppm; IR (NaCl): n˜ =3057, 2963, 2934, 2139,
8.17 (m, 1H), 7.79–7.76 (m, 1H), 7.56–7.52 (m, 2H), 7.49–7.44 (m, 2H),
3.90 (q, J=7.2 Hz, 4H), 1.39 (t, J=7.2 Hz, 6H), 0.26 ppm (s, 9H);
13C NMR (CDCl3): d=150.5, 133.8, 130.2, 128.4, 127.5, 126.5, 125.7,
124.2, 124.1, 109.8, 105.0, 95.9, 48.6, 41.1, 14.4, 11.0, 0.07 ppm; IR (NaCl):
n˜ =3055, 2963, 2933, 2142, 1466, 1413, 1337, 1247 cmÀ1; HRMS (ESI): m/
z: calcd for C19H25N3Si: 323.1818, found 323.1827.
1617, 1588, 1405, 1329, 1247 cmÀ1
C19H25N3Si: 323.1818, found 323.1813.
; HRMS (ESI): m/z: calcd for
Azo–ene–yne 6: Alkyne 13 (0.40 g, 1.2 mmol) was deprotected according
to general procedure C. Terminal alkyne 6 (0.29 g, 97%) was isolated as
a red oil and used without further purification. 1H NMR (CDCl3): d=
8.48 (d, J=8.1 Hz, 1H), 7.82 (d, J=7.8 Hz, 1H), 7.81–7.78 (m, 2H), 7.59
(t, J=7.8 Hz, 1H), 7.45 (t, J=7.8 Hz, 1H), 4.0–3.8 (m, 4H), 3.78 (s, 1H),
1.36 ppm (t, J=6.9 Hz, 6H); 13C NMR (CDCl3): d=151.8, 134.5, 131.0,
129.3, 127.9, 126.8, 125.8, 125.0, 116.7, 112.3, 86.4, 79.9, 49.0, 41.8, 14.4,
10.8 ppm; IR (NaCl): n˜ =3290, 3057, 3974, 2933, 2871, 2094, 1616, 1588,
1451, 1403, 1328, 1243 cmÀ1; HRMS (ESI): m/z: calcd for C16H17N3:
251.1422, found 251.1433.
Azo–ene–yne 7: Alkyne 19 (0.625 g, 1.91 mmol) was deprotected accord-
ing to general procedure C. Terminal alkyne 7 (0.497 g, 99%) was isolat-
ed as
(CDCl3): d=8.24–8.20 (m, 1H), 7.81–7.78 (m, 1H), 7.60–7.45 (m, 4H),
3.88 (q, J=7.2 Hz, 4H), 3.12 (s, 1H), 1.38 ppm (t, J=7.2 Hz, 6H);
13C NMR (CDCl3): d=151.0, 134.0, 130.2, 127.8, 127.6, 126.7, 125.9,
125.5, 124.3, 118.1, 83.7, 78.8, 52.5, 12.3 ppm; IR (NaCl): n˜ =3289, 3053,
2974, 2933, 2871, 2095, 1672, 1448, 1340, 1242 cmÀ1; HRMS (ESI): m/z:
calcd for C16H17N3: 251.1422, found 251.1412.
a
yellow oil and used without further purification. 1H NMR
Benzo[h]cinnoline 20: Alkyne 7 (35 mg, 0.14 mmol) was cyclized accord-
ing to general procedure D. Purification by preparative TLC (1:1 hex-
anes/EtOAc) afforded 20 (15 mg, 60%) as a light brown solid. 1H NMR
(CDCl3): d=9.61 (dd, J=7.2, 1.8 Hz, 1H), 9.46 (d, J=8.7 Hz, 1H), 7.99
(d, J=8.7 Hz, 1H), 7.95 (dd, J=7.2, 1.8 Hz, 1H), 7.90–7.77 (m, 3H),
7.63 ppm (d, J=8.7 Hz, 1H); 13C NMR (CDCl3): d=147.3, 133.4, 133.2,
129.9, 129.6, 128.8, 128.2, 125.9, 124.4, 123.3, 122.8, 105.0 ppm; IR
(NaCl): n˜ =3053, 2923, 2853, 1607, 1579, 1499, 1414, 1366 cmÀ1; HRMS
(ESI): m/z: calcd for C12H8N2: 180.0687, found 180.0675.
Benzo[f]cinnoline 14: Azo–ene–yne 6 (0.115 g, 0.45 mmol) was heated
according to general procedure D. Purification by preparative TLC (2:1
EtOAc/hexanes) afforded 14 (0.051 g, 63%) as a tan solid. 1H NMR
(CDCl3): d=9.44 (d, J=6.0 Hz, 1H), 8.66–8.60 (m, 1H), 8.51 (d, J=
6.0 Hz, 1H), 8.28 (d, J=9.0 Hz, 1H), 8.03 (d, J=9.0 Hz, 1H), 7.98–7.92
(m, 1H), 7.82–7.70 ppm (m, 2H); 13C NMR (CDCl3): d=150.5, 146.7,
132.9, 132.3, 129.9, 128.9, 127.8, 127.7, 126.5, 125.5, 123.7, 118.2 ppm; IR
(NaCl): n˜ =2924, 2853, 1595, 1404, 1269 cmÀ1; HRMS (ESI): m/z: calcd
for C12H8N2: 180.0687, found 180.0701.
Benzo[g]isoindazole 21 and dimer 22: Alkyne 7 (35 mg, 0.14 mmol) was
cyclized according to general procedure E. Purification by preparative
TLC (9:1 hexanes/ EtOAc) afforded 21 (10 mg, 27%) as a tan solid and
22 (16 mg, 46%) as a yellow solid. If the DCE solution was saturated
with O2 prior to CuCl addition, 21 was isolated in 71% yield, with no evi-
dence of dimer formation. 21: 1H NMR (CDCl3): d=10.45 (s, 1H), 8.63–
8.60 (m, 1H), 8.09 (d, J=9.3 Hz, 1H), 7.88 (dd, J=6.9, 1.8 Hz, 1H),
7.70–7.57 (m, 3H), 3.55 (br s, 2H), 3.28 (br s, 2H), 0.90 ppm (t, J=
7.2 Hz, 6H); 13C NMR (CDCl3): d=182.1, 143.3, 133.4, 132.4, 128.6,
128.1, 127.2, 127.1, 125.1, 122.5, 118.6, 117.2, 52.6, 12.1 ppm; IR (NaCl):
n˜ =3049, 2974, 2934, 2855, 1672, 1551, 1440 cmÀ1; HRMS (ESI): m/z:
Benzo[e]isoindazole 15: Azo–ene–yne 6 (40 mg, 0.15 mmol) was dis-
solved in 1,2-dichloroethane (100 mL), and the solution was saturated
with O2 for 30 min. CuCl (200 mg) was added and the reaction was car-
ried out according to general procedure E. Purification by preparative
TLC (Et2O) gave 15 (26 mg, 65%) as a red oil. 1H NMR (CDCl3): d=
10.67 (s, 1H), 9.54 (dd, J=8.1, 1.2 Hz, 1H), 7.88 (dd, J=8.4, 1.2 Hz, 1H),
7.75–7.60 (m, 4H), 3.6–3.5 (m, 2H), 3.3–3.2 (m, 2H), 0.90 ppm (t, J=
7.5 Hz, 6H); 13C NMR (CDCl3): d=182.6, 145.0, 135.1, 132.0, 129.7,
128.6, 127.7, 127.2, 127.1, 126.9, 117.1, 116.9, 52.6, 12.0 ppm; IR (NaCl):
n˜ =2923, 2853, 1676, 1618, 1442 cmÀ1; HRMS (ESI): m/z: calcd for
C16H17N3O: 267.1372, found 267.1394.
1
calcd for C16H17N3O 267.1372, found 267.1387. 22: H NMR (CDCl3): d=
8.68–8.60 (m, 2H), 8.01 (s, 2H), 7.92–7.84 (m, 4H), 7.63–7.51 (m, 6H),
3.58 (br s, 4H), 3.28 (br s, 4H), 0.94 ppm (t, J=7.5 Hz, 12H); 13C NMR
(CDCl3): d=143.8, 134.9, 132.3, 128.2, 126.6, 126.5, 125.6, 124.0, 122.6,
118.8, 118.1, 113.9, 52.5, 12.3 ppm; IR (NaCl): n˜ =3053, 2974, 2862, 1548,
Dimers 16 and 17: Alkyne 6 (50 mg, 0.19 mmol) was dissolved in dry 1,2-
dichloroethane (40 mL) and purged with Ar for 30 min. [{RhACTHNUTRGNE(UNG OAc)2}2]
(5 mol%) was added and heated to 508C with stirring. Upon completion,
the reaction was cooled and filtered through a pad of silica. Concentra-
tion in vacuo and purification by preparative TLC (CH2Cl2) gave trans
dimer 16 (22 mg, 46%) as a tan solid. 1H NMR (CDCl3): d=8.82–8.79
(m, 2H), 8.46 (s, 2H), 7.88–7.85 (m, 2H), 7.70–7.62 (m, 4H), 7.52–7.44
(m, 4H), 3.6–3.5 (m, 4H), 3.35–3.25 (m, 4H), 0.98 ppm (t, J=7.2 Hz,
12H); 13C NMR (CDCl3): d=145.3, 135.0, 131.1, 129.4, 128.7, 128.5,
126.5, 124.9, 123.1, 122.4, 117.9, 113.1, 52.6, 11.9 ppm; IR (NaCl): n˜ =
2973, 2933, 2855, 1553, 1440 cmÀ1; HRMS (ESI): m/z: calcd for C32H34N6:
502.2845, found 502.2869. The NMR sample of 16 in CDCl3 (ca. 0.7 mL)
was allowed to stand at room temperature for 36 h exposed to ambient
light. Removal of the solvent afforded cis dimer 17 (22 mg, 100%) as a
tan solid. 1H NMR (CDCl3): d=8.13 (d, J=7.5 Hz, 2H), 7.72 (d, J=
7.5 Hz, 2H), 7.55–7.43 (m, 4H), 7.41 (s, 2H), 7.27 (m, 2H), 7.0–6.9 (br m,
2H), 3.0–2.6 (m, 8H), 0.65 ppm (t, J=7.2 Hz, 12H); 13C NMR (CDCl3):
d=144.8, 133.7, 130.5, 128.5, 128.3, 128.1, 125.8, 124.6, 123.9, 122.4, 117.5,
1446 cmÀ1
502.2832.
; HRMS (ESI): m/z: calcd for C32H34N6: 502.2845, found
Dimer 22 using [{Rh
ACHTUNGTRENNUNG
solved in DCE (10 mL) and purged with Ar for 45 min. [{RhAHCTUNGTRENNUNG
mol%) was added and the reaction mixture was stirred at room tempera-
ture. Filtration through a pad of silica followed by purification by prepa-
rative TLC (9:1 hexanes/EtOAc) afforded 22 (27 mg, 55%) as a yellow
solid whose spectral data matched those above.
Dibromide 24: CBr4 (5.24 g, 7.8 mmol) was added to a solution of PPh3
(8.2 g, 15.6 mmol) in CH2Cl2 (80 mL) at 08C. The reaction mixture was
stirred for 30 min then warmed to room temperature over 30 min. Alde-
hyde 23[17] (1.0 g, 3.9 mmol) in DCM (25 mL) was added by cannula and
the reaction mixture was stirred at room temperature. Upon completion,
pentane (200 mL) was added. The resultant precipitate was filtered off
and the solvent removed in vacuo. Purification by column chromatogra-
phy (1:1 Et2O/hexanes) provided 24 (0.86 g, 54%) as a yellow solid.
1H NMR (CDCl3): d=8.54 (s, 1H), 7.80–7.74 (m, 3H), 7.59 (br s, 1H),
7.53 (s, 1H), 7.50–7.73 (m, 3H), 1.38 ppm (s, 9H); 13C NMR (CDCl3): d=
176.7, 133.9, 133.4, 131.8, 130.0, 128.0, 127.7, 127.6, 127.5, 126.9, 125.5,
119.7, 95.3, 39.6, 27.4 ppm; IR (NaCl): n˜ =3275, 2975, 2934, 2869, 1688,
1653, 1590, 1448, 1260 cmÀ1; HRMS (ESI): m/z: calcd for C17H17Br2NO
408.9677, found 408.9698.
113.8, 51.1, 11.7 ppm; IR (NaCl): n˜ =2973, 2933, 2856, 1452, 1379 cmÀ1
HRMS (ESI): m/z: calcd for C32H34N6: 502.2845, found 502.2857.
;
Triazene 18: Bromoamine 10[15] (1.0 g, 4.5 mmol) was allowed to react ac-
cording to general procedure A. Purification by column chromatography
(9:1 hexanes/CH2Cl2) furnished 18 (1.08 g, 79%) as a red oil. 1H NMR
(CDCl3): d=7.96–7.91 (m, 1H), 7.83–7.78 (m, 1H), 7.65 (d, J=8.7 Hz,
1H), 7.52–7.48 (m, 3H), 4.0–3.8 (m, 4H), 1.39 ppm (t, J=7.2 Hz, 6H);
13C NMR (CDCl3): d=146.2, 133.5, 130.4, 129.4, 127.9, 126.3, 126.1,
125.8, 124.0, 112.7, 49.1, 41.5, 14.9, 11.3 ppm; IR (NaCl): n˜ =2974, 2932,
Amine 25: A solution of 24 (0.5 g, 1.2 mmol) in EtOH (25 mL) and HCl
(2m, 45 mL) was refluxed overnight. Upon cooling, the resultant precipi-
tate was removed by filtration. The filtrate was neutralized with aqueous
NaHCO3 solution to pH 8, then extracted twice with CH2Cl2. The com-
bined organics were dried (MgSO4), filtered through a short pad of silica,
and concentrated in vacuo to give 25 (0.40 g, 96%) as a tan solid.
1580, 1466, 1409, 1339, 1242 cmÀ1
C14H16BrN3: 305.0528, found 305.0511.
; HRMS (ESI): m/z: calcd for
Alkyne 19: Bromotriazene 18 (0.675 g, 2.1 mmol) was allowed to react
according to general procedure B at 508C. Alkyne 19 (0.635 g, 94%) was
isolated as a yellow oil of sufficient purity. 1H NMR (CDCl3): d=8.20–
6804
ꢄ 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2011, 17, 6798 – 6806